Tags

Type your tag names separated by a space and hit enter

[Progress and analysis on the development of 2019-nCoV vaccine].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Jun 25; 37(3):373-379.SW

Abstract

As the COVID-19 pandemic is intensifying globally, more and more people are pinning their hopes on the development of vaccines. At present, there are many research teams who have adopted different vaccine technology routes to develop 2019-nCoV vaccines. This article reviews and analyzes the current development and research status of 2019-nCoV vaccines in different routes, and explores their possible development in the future.

Authors+Show Affiliations

College of Life Science, Leshan Normal University, Leshan, Sichuan 614000, P.R.China;Department of Biotechnology, Chengdu Institute of Biological Products, Chengdu 610000, P.R.China.College of Life Science, Leshan Normal University, Leshan, Sichuan 614000, P.R.China.

Pub Type(s)

Journal Article
Review

Language

chi

PubMed ID

32597077

Citation

Kang, Zhuang, and Mei Tang. "[Progress and Analysis On the Development of 2019-nCoV Vaccine]." Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi, vol. 37, no. 3, 2020, pp. 373-379.
Kang Z, Tang M. [Progress and analysis on the development of 2019-nCoV vaccine]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020;37(3):373-379.
Kang, Z., & Tang, M. (2020). [Progress and analysis on the development of 2019-nCoV vaccine]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi, 37(3), 373-379. https://doi.org/10.7507/1001-5515.202004025
Kang Z, Tang M. [Progress and Analysis On the Development of 2019-nCoV Vaccine]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Jun 25;37(3):373-379. PubMed PMID: 32597077.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Progress and analysis on the development of 2019-nCoV vaccine]. AU - Kang,Zhuang, AU - Tang,Mei, PY - 2020/6/30/entrez PY - 2020/7/1/pubmed PY - 2020/7/2/medline KW - 2019-nCoV KW - attenuated live vaccine KW - inactivated vaccine KW - nucleic acid vaccine KW - recombinant protein vaccine SP - 373 EP - 379 JF - Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi JO - Sheng Wu Yi Xue Gong Cheng Xue Za Zhi VL - 37 IS - 3 N2 - As the COVID-19 pandemic is intensifying globally, more and more people are pinning their hopes on the development of vaccines. At present, there are many research teams who have adopted different vaccine technology routes to develop 2019-nCoV vaccines. This article reviews and analyzes the current development and research status of 2019-nCoV vaccines in different routes, and explores their possible development in the future. SN - 1001-5515 UR - https://www.unboundmedicine.com/medline/citation/32597077/[Progress_and_analysis_on_the_development_of_2019_nCoV_vaccine]_ DB - PRIME DP - Unbound Medicine ER -